Hormone Replacement Therapy Market size was valued at USD 15.88 billion in 2023 and is expected to reach at USD 25.32 billion by 2031, and grow at a CAGR of 6.01% over the forecast period of 2024-2031.
In order to cure symptoms brought on by hormonal imbalances or deficiencies, a medical procedure known as hormone replacement therapy (HRT) involves adding extra hormones to the body or replacing those that are already there. Although it can be prescribed for other diseases as well, it is most frequently used to treat the symptoms that women experience during the menopause. A woman's ovaries gradually generate fewer hormones, especially oestrogen and progesterone, during menopause. Numerous symptoms, including hot flashes, nocturnal sweats, mood swings, vaginal dryness, and sleep difficulties, might be brought on by this hormonal drop. HRT seeks to reduce these symptoms and raise the general standard of living for menopausal women.
Get More Information on Hormone Replacement Therapy Market - Request Sample Report
HRT can be given in a variety of ways, including tablets, patches, gels, lotions, vaginal rings, and more. Various elements, including personal preferences, medical history, and the particular symptoms being treated, affect the administration method choice.
The major types of HRT are Combined and Oestrogen-only HRT. While HRT can effectively control menopausal symptoms, it is crucial to remember that there are hazards involved. HRT use over an extended period of time has been linked to a number of health issues, including an elevated risk of blood clots, stroke, heart disease, and breast cancer. However, each person should undergo a personalised assessment of the dangers and advantages of HRT, taking into consideration their age, medical history, and personal preferences. For those on HRT, regular monitoring and medical expert visits are essential.
Driver :
The rise in the awareness of the HRT.
The use of HRT has changed over time as a result of a variety of variables, including alterations in medical recommendations, more public awareness, and shifting opinions on hormone therapy. Changes in the population, advances in medical science, and shifting cultural perspectives on disorders linked to hormones can all have an impact on the popularity and usage of HRT.
Restrain :
The patient’s history is a point of concern for carrying out HRT.
The use of HRT may be contraindicated due to certain medical issues. For instance, because to the elevated risks involved with these illnesses, HRT may not be recommended for those with a history of certain types of breast or uterine cancer, blood clots, liver disease, uncontrolled high blood pressure, or a history of stroke.
Opportunity :
Prevention and treatment of specific medical disorders:
It has been discovered that HRT, particularly oestrogen therapy, may have potential preventive effects on a number of conditions. For instance, by maintaining bone density and lowering the risk of fractures, it can aid in lowering the risk of osteoporosis. In addition, early HRT initiation in menopausal women may offer cardiovascular advantages, including increased arterial flexibility and a lower risk of heart disease.
Challenge :
The risk associated with HRT
HRT carries certain health risks, and the equilibrium between benefits and risks should be carefully assessed for each individual. An increased risk of blood clots, heart disease, stroke, breast cancer, and gallbladder disease are some of the hazards connected with HRT. Various factors, including age, the type of hormone administered, the length of the treatment, and a person's health profile, can affect the risks.
Financial hardships brought on by economic downturns can make it challenging for people to pay for the costs of HRT, including prescription drugs, doctor visits, and laboratory testing. Financial difficulties in receiving HRT may be made worse by insufficient coverage from insurance or changes to insurance policies. Due to financial worries, people may use their healthcare services less frequently overall during a recession. This can entail putting off or skipping unnecessary doctor visits, which might influence HRT-related monitoring and follow-up visits.
By Therapy Type
Estrogen Hormone replacement Therapy
Human growth Hormone Replacement Therapy
Testosterone Hormone replacement Therapy
Others
By Route of Administration
Oral
Parenteral
Others
By Indication
Menopause
Hypothyroidism
Others
Due to an increase in generic hormone replacement therapy product launches by manufacturers, an increase in the target market, innovations in drug delivery systems, and the development of new formulations, the North American market saw the greatest increase in terms of revenue in 2019. On the other hand, the Asia-Pacific market is anticipated to experience the largest CAGR in terms of revenue over the course of the forecast period due to rising awareness of hormone replacement therapy, an alarming rise in diabetes prevalence, and an increased focus on treating hormonal deficiencies among healthcare providers in China, India, and Japan.
Get Customized Report as per Your Business Requirement - Request For Customized Report
The major key players are Eli Lilly and Company, Hisamitsu Pharmaceutical Co, Pfizer, Bayer Ag, Abbott Laboratories, Novo Nordisk, Novartis International, Merck KGAA, Hoffmann- LA Roche Ltd.
| Report Attributes | Details |
| Market Size in 2023 | US$ 15.88 Bn |
| Market Size by 2031 | US$ 25.32 Bn |
| CAGR | CAGR of 6.01% From 2024 to 2031 |
| Base Year | 2023 |
| Forecast Period | 2024-2031 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Therapy Type (Estrogen Hormone Replacement Therapy, Human growth hormone Replacement Therapy, Testosterone Hormone replacement Therapy, Others) • By route of Administration (Oral, Parenteral, Others) • By Indication (Menopause, Hypothyroidism, Others) |
| Regional Analysis/Coverage | North America (USA, Canada, Mexico), Europe (Germany, UK, France, Italy, Spain, Netherlands, Rest of Europe), Asia-Pacific (Japan, South Korea, China, India, Australia, Rest of Asia-Pacific), The Middle East & Africa (Israel, UAE, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America) |
| Company Profiles | Eli Lilly and Company, Hisamitsu Pharmaceutical Co, Pfizer, Bayer Ag, Abbott Laboratories, Novo Nordisk, Novartis International, Merck KGAA, Hoffmann- LA Roche Ltd. |
| Key Drivers | • The rise in the awareness of the HRT. |
| Market Opportunities | • Prevention and treatment of specific medical disorders |
Ans: The rise in the awareness of the HRT.
Ans: The Hormone Replacement Therapy Market size was valued at USD 14.98 billion in 2022 and is expected to reach at USD 23.70 billion by 2030, and grow at a CAGR of 5.9% over the forecast period of 2023-2030.
Ans: Market is divided in three segments by Therapy Type, by Route of Administration and by Indication.
Ans: The North American market saw the greatest increase in terms of revenue in 2019. On the other hand, the Asia-Pacific market is anticipated to experience the largest CAGR in terms of revenue over the course of the forecast period.
Ans : HRT carries certain health risks, and the equilibrium between benefits and risks should be carefully assessed for each individual
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
4.1 COVID 19 Impact Analysis
4.2 Impact of ongoing Recession
4.2.1 Introduction
4.2.2 Impact on major economies
4.2.2.1 US
4.2.2.2 Canada
4.2.2.3 Germany
4.2.2.4 France
4.2.2.5 United Kingdom
4.2.2.6 China
4.2.2.7 Japan
4.2.2.8 South Korea
4.2.2.9 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Hormone Replacement Therapy Market Segmentation By Therapy Type
8.1 Estrogen hormone replacement therapy
8.2 Human growth hormone Replacement Therapy
8.3 Testosterone Hormone replacement Therapy
8.4 Others
9. Hormone Replacement Therapy Market Segmentation By Route of Administration
9.1 Oral
9.2 Parenteral
9.3 Others
10. Hormone Replacement Therapy Market Segmentation By Indication
10.1 Menopause
10.2 Hypothyroidism
10.3 Others
11. Regional Analysis
11.1 Introduction
11.2 North America
11.2.1 North America Hormone Replacement Therapy Market by country
11.2.2North America Hormone Replacement Therapy Market by Therapy Type
11.2.3 North America Hormone Replacement Therapy Market by Route of Administration
11.2.4 North America Hormone Replacement Therapy Market by Indication
11.2.5 USA
11.2.5.1 USA Hormone Replacement Therapy Market by Therapy Type
11.2.5.3 USA Hormone Replacement Therapy Market by Route of Administration
11.2.5.4 USA Hormone Replacement Therapy Market by Indication
11.2.6 Canada
11.2.6.1 Canada Hormone Replacement Therapy Market by Therapy Type
11.2.6.3 Canada Hormone Replacement Therapy Market by Route of Administration
11.2.6.4 Canada Hormone Replacement Therapy Market by Indication
11.2.7 Mexico
11.2.7.1 Mexico Hormone Replacement Therapy Market by Therapy Type
11.2.7.3 Mexico Hormone Replacement Therapy Market by Route of Administration
11.2.7.4 Mexico Hormone Replacement Therapy Market by Indication
11.3 Europe
11.3.1 Europe Hormone Replacement Therapy Market by country
1.3.3.2 Europe Hormone Replacement Therapy Market by Therapy Type
11.3.3 Europe Hormone Replacement Therapy Market by Route of Administration
11.3.4 Europe Hormone Replacement Therapy Market by Indication
11.3.5 Germany
11.3.5.1 Germany Hormone Replacement Therapy Market by Therapy Type
11.3.5.2 Germany Hormone Replacement Therapy Market by Route of Administration
11.3.5.3 Germany Hormone Replacement Therapy Market by Indication
11.3.6 UK
11.3.6.1 UK Hormone Replacement Therapy Market by Therapy Type
11.3.6.2 UK Hormone Replacement Therapy Market by Route of Administration
11.3.6.3 UK Hormone Replacement Therapy Market by Indication
11.3.7 France
11.3.7.1 France Hormone Replacement Therapy Market by Therapy Type
11.3.7.2 France Hormone Replacement Therapy Market by Route of Administration
11.3.7.3 France Hormone Replacement Therapy Market by Indication
11.3.8 Italy
11.3.8.1 Italy Hormone Replacement Therapy Market by Therapy Type
11.3.8.2 Italy Hormone Replacement Therapy Market by Route of Administration
11.3.8.3 Italy Hormone Replacement Therapy Market by Indication
11.3.9 Spain
11.3.9.1 Spain Hormone Replacement Therapy Market by Therapy Type
11.3.9.2 Spain Hormone Replacement Therapy Market by Route of Administration
11.3.9.3 Spain Hormone Replacement Therapy Market by Indication
11.3.10 The Netherlands
11.3.10.1 Netherlands Hormone Replacement Therapy Market by Therapy Type
11.3.10.2 Netherlands Hormone Replacement Therapy Market by Route of Administration
11.3.10.3 Netherlands Hormone Replacement Therapy Market by Indication
11.3.11 Rest of Europe
11.3.11.1 Rest of Europe Hormone Replacement Therapy Market by Therapy Type
11.3.11.2 Rest of Europe Hormone Replacement Therapy Market by Route of Administration
11.3.11.3 Rest of Europe Hormone Replacement Therapy Market by Indication
11.4 Asia-Pacific
11.4.1 Asia Pacific Hormone Replacement Therapy Market by country
11.4.2 Asia Pacific Hormone Replacement Therapy Market by Therapy Type
11.4.3 Asia Pacific Hormone Replacement Therapy Market by Route of Administration
11.4.4 Asia Pacific Hormone Replacement Therapy Market by Indication
11.4.5 Japan
11.4.5.1 Japan Hormone Replacement Therapy Market by Therapy Type
11.4.5.2 Japan Hormone Replacement Therapy Market by Route of Administration
11.4.5.3 Japan Hormone Replacement Therapy Market by Indication
11.4.6 South Korea
11.4.6.1 South Korea Hormone Replacement Therapy Market by Therapy Type
11.4.6.2 South Korea Hormone Replacement Therapy Market by Route of Administration
11.4.6.3 South Korea Hormone Replacement Therapy Market by Indication
11.4.7 China
11.4.7.1 China Hormone Replacement Therapy Market by Therapy Type
11.4.7.2 China Hormone Replacement Therapy Market by Route of Administration
11.4.7.3 China Hormone Replacement Therapy Market by Indication
11.4.8 India
11.4.8.1 India Hormone Replacement Therapy Market by Therapy Type
11.4.8.2 India Hormone Replacement Therapy Market by Route of Administration
11.4.8.3 India Hormone Replacement Therapy Market by Indication
11.4.9 Australia
11.4.9.1 Australia Hormone Replacement Therapy Market by Therapy Type
11.4.9.2 Australia Hormone Replacement Therapy Market by Route of Administration
11.4.9.3 Australia Hormone Replacement Therapy Market by Indication
11.4.10 Rest of Asia-Pacific
11.4.10.1 APAC Hormone Replacement Therapy Market by Therapy Type
11.4.10.2 APAC Hormone Replacement Therapy Market by Route of Administration
11.4.10.3 APAC Hormone Replacement Therapy Market by Indication
11.5 The Middle East & Africa
11.5.1 The Middle East & Africa Hormone Replacement Therapy Market by country
11.5.2 The Middle East & Africa Hormone Replacement Therapy Market by Therapy Type
11.5.3 The Middle East & Africa Hormone Replacement Therapy Market by Route of Administration
11.5.4 The Middle East & Africa Hormone Replacement Therapy Market by Indication
11.5.6 Israel
11.5.6.1 Israel Hormone Replacement Therapy Market by Therapy Type
11.5.6.2 Israel Hormone Replacement Therapy Market by Route of Administration
11.5.6.3 Israel Hormone Replacement Therapy Market by Indication
11.5.6 UAE
11.5.6.1 UAE Hormone Replacement Therapy Market by Therapy Type
11.5.6.2 UAE Hormone Replacement Therapy Market by Route of Administration
11.5.6.3 UAE Hormone Replacement Therapy Market by Indication
11.5.7 South Africa
11.5.7.1 South Africa Hormone Replacement Therapy Market by Therapy Type
Therapy Type
11.5.7.2 South Africa Hormone Replacement Therapy Market by Route of Administration
11.5.7.3 South Africa Hormone Replacement Therapy Market by Indication
11.5.8 Rest of Middle East & Africa
11.5.8.1 Rest of Middle East & Asia Hormone Replacement Therapy Market by Therapy Type
11.5.8.2 Rest of Middle East & Asia Hormone Replacement Therapy Market Phase
11.5.8.3 Rest of Middle East & Asia Hormone Replacement Therapy Market by Indication
11.6 Latin America
11.6.1 Latin America Hormone Replacement Therapy Market by country
11.6.2 Latin America Hormone Replacement Therapy Market by Therapy Type
11.6.3 Latin America Hormone Replacement Therapy Market by Route of Administration
11.6.4 Latin America Hormone Replacement Therapy Market by Indication
11.6.5 Brazil
11.6.5.1 Brazil Hormone Replacement Therapy Market by Therapy Type
11.6.5.2 Brazil Hormone Replacement Therapy Market by Route of Administration
11.6.2.3 Brazil Hormone Replacement Therapy Market by Indication
11.6.6 Argentina
11.6.6.1 Argentina Hormone Replacement Therapy Market by Therapy Type
11.6.6.2 Argentina Hormone Replacement Therapy Market by Route of Administration
11.6.6.3 Argentina Hormone Replacement Therapy Market by Indication
11.6.7 Rest of Latin America
11.6.7.1 Rest of Latin America Hormone Replacement Therapy Market by Therapy Type
11.6.7.2 Rest of Latin America Hormone Replacement Therapy Market by Route of Administration
11.6.7.3 Rest of Latin America Hormone Replacement Therapy Market by Indication
12. Company Profile
12.1 Eli Lilly and Company
12.1.1 Market Overview
12.1.2 Financials
12.1.3 Product /Services/Offerings
12.1.4 SWOT Analysis
12.1.5 The SNS View
12.2 Hisamitsu Pharmaceutical Co
12.2.1 Market Overview
12.2.2 Financials
12.2.3 Product /Services/Offerings
12.2.4 SWOT Analysis
12.2.5 The SNS View
12.3 Pfizer
12.3.1 Market Overview
12.3.2 Financials
12.3.3 Product /Services/Offerings
12.3.4 SWOT Analysis
12.3.5 The SNS View
12.4 Bayer Ag
12.4.1 Market Overview
12.4.2 Financials
12.4.3 Product /Services/Offerings
12.4.4 SWOT Analysis
12.4.5 The SNS View
12.5 Abbott Laboratories
12.5.1 Market Overview
12.5.2 Financials
12.5.3 Product /Services/Offerings
12.5.4 SWOT Analysis
12.5.5 The SNS View
12.6 Novo Nordisk
12.6.1 Market Overview
12.6.2 Financials
12.6.3 Product /Services/Offerings
12.6.4 SWOT Analysis
12.6.5 The SNS View
12.7 Novartis International
12.7.1 Market Overview
12.7.2 Financials
12.7.3 Product /Services/Offerings
12.7.4 SWOT Analysis
12.7.5 The SNS View
12.8 Merck KGAA,
12.8.1 Market Overview
12.8.2 Financials
12.8.3 Product /Services/Offerings
12.8.4 SWOT Analysis
12.8.5 The SNS View
12.9 Hoffmann- LA Roche Ltd
12.9.1 Market Overview
12.9.2 Financials
12.9.3 Product /Services/Offerings
12.9.4 SWOT Analysis
12.9.5 The SNS View
12.10 Parexel international Corporation
12.10.1 Market Overview
12.10.2 Financials
12.10.3 Product /Services/Offerings
12.10.4 SWOT Analysis
12.10.5 The SNS View
13. Competitive Landscape
13.1 Competitive Benchmarking
13.2 Market Share analysis
13.3 Recent Developments
14. Use cases and Best Practices
15. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The Biomarkers Market, size was estimated USD 66.8 billion in 2022 and is expected to reach USD182.6 billion by 2030 at a CAGR of 13.4% during the forecast period of 2023-2030.
The Long-term Care Software Market Size was valued at USD 2.77 billion in 2022, and expected to reach USD 7.33 billion by 2030, and grow at a CAGR of 12.9% over the forecast period 2023-2030.
The Positron Emission Tomography Market size was estimated USD 2.5 billion in 2022 and is expected to reach USD 3.93 billion by 2030 at a CAGR of 6.7% during the forecast period of 2023-2030.
In 2022, The Smart Contact Lenses Market size amounted to USD 445.28 Million & is estimated to reach USD 6098.80 Million by 2030 and increase at a compound annual growth rate of 38.7% between 2023 and 2030.
The Single-Use Bioreactors Market Size was valued at USD 3.01 billion in 2022 and is expected to reach USD 10.72 billion by 2030 and grow at a CAGR of 17.2% over the forecast period 2023-2030.
The Medical Device Reprocessing Market size was estimated at USD 2.2 billion in 2022 and is expected to reach USD 6.10 billion by 2030 at a CAGR of 13.6% during the forecast period of 2023-2030.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
